236 related articles for article (PubMed ID: 36564416)
1. Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study.
Yu Z; Qin E; Cheng S; Yang H; Liu R; Xu T; Liu Y; Yuan J; Yu S; Yang J; Liang F
Sci Rep; 2022 Dec; 12(1):22184. PubMed ID: 36564416
[TBL] [Abstract][Full Text] [Related]
2. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
3. Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.
Yang J; Wang E; Jiang M; Tan Y; Yao F; Sun C; Pan L; Gao L; Yao J
J Ovarian Res; 2023 Jun; 16(1):109. PubMed ID: 37277785
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
5. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients.
Chen F; Chen Z; Chen M; Chen G; Huang Q; Yang X; Yin H; Chen L; Zhang W; Lin H; Ou M; Wang L; Chen Y; Lin C; Xu W; Yin G
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):60. PubMed ID: 34267209
[TBL] [Abstract][Full Text] [Related]
6. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
7. Blood Bacterial 16S rRNA Gene Alterations in Women With Polycystic Ovary Syndrome.
Wang Q; Wang Q; Zhao L; Bin Y; Wang L; Wang L; Zhang K; Li Q
Front Endocrinol (Lausanne); 2022; 13():814520. PubMed ID: 35282443
[TBL] [Abstract][Full Text] [Related]
8.
Luo M; Chen Y; Pan X; Chen H; Fan L; Wen Y
Front Immunol; 2023; 14():1137089. PubMed ID: 37275915
[TBL] [Abstract][Full Text] [Related]
9. Effect of the ketogenic diet on gut microbiome composition and metabolomics in polycystic ovarian syndrome rats induced by letrozole and a high-fat diet.
Wang R; Zhao Y; Fang X; Miao C; Ren N; Chen Y; Cheng W; Zhang Q
Nutrition; 2023 Oct; 114():112127. PubMed ID: 37441825
[TBL] [Abstract][Full Text] [Related]
10. Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China.
Li G; Liu Z; Ren F; Shi H; Zhao Q; Song Y; Fan X; Ma X; Qin G
Front Microbiol; 2022; 13():911992. PubMed ID: 35847083
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
12. Integrating 16S RRNA gene sequencing and metabolomics to evaluate the association between gut microbiota and serum metabolites in patients with myositis.
Luo YB; Liu Y; Li Q; Duan H; Luo Z; Yang H; Xu L
J Appl Microbiol; 2022 Oct; 133(4):2547-2559. PubMed ID: 35858765
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the vaginal microbiome of healthy and polycystic ovary syndrome women: a large cross-sectional study.
Jin C; Qin L; Liu Z; Li X; Gao X; Cao Y; Zhao S; Wang J; Han T; Yan L; Song J; Zhang F; Liu F; Zhang Y; Huang Y; Song Y; Liu Y; Yao Z; Chen H; Zhang Z; Zhao S; Feng Y; Zhang YN; Qian Y; Sun T; Feng Q; Zhao H
Reprod Biomed Online; 2023 Jun; 46(6):1005-1016. PubMed ID: 37085428
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota disorder induces liver dysfunction in polycystic ovary syndrome rats' model by regulating metabolite rosmarinic acid.
Zhang T; Gao H; Fan Y; Chen S; Li Y; Liu R; Li T; Yin C
Life Sci; 2023 Oct; 330():121912. PubMed ID: 37423380
[TBL] [Abstract][Full Text] [Related]
16. Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites.
Shen HR; Xu X; Ye D; Li XL
Gynecol Obstet Invest; 2021; 86(4):388-397. PubMed ID: 34515131
[TBL] [Abstract][Full Text] [Related]
17. Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: A systematic review and meta-analysis.
Zou Y; Liao R; Cheng R; Chung H; Zhu H; Huang Y
Microb Pathog; 2023 Nov; 184():106370. PubMed ID: 37739322
[TBL] [Abstract][Full Text] [Related]
18. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction.
Li T; Zhang T; Gao H; Liu R; Gu M; Yang Y; Cui T; Lu Z; Yin C
Redox Biol; 2021 May; 41():101886. PubMed ID: 33592539
[TBL] [Abstract][Full Text] [Related]
19. Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole.
Li Y; Zhu Y; Li D; Liu W; Zhang Y; Liu W; Zhang C; Tao T
Front Endocrinol (Lausanne); 2023; 14():1265152. PubMed ID: 37929036
[TBL] [Abstract][Full Text] [Related]
20. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population.
Mammadova G; Ozkul C; Yilmaz Isikhan S; Acikgoz A; Yildiz BO
Eur J Clin Invest; 2021 Apr; 51(4):e13417. PubMed ID: 32991745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
